Patents by Inventor Jeong Won HONG

Jeong Won HONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody binding to carbonic anhydrase and use thereof
    Patent number: 11820831
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: November 21, 2023
    Assignee: APROGEN INC.
    Inventors: Yoo Ri Moon, Sangsoon Yoon, Jeong Won Hong, Eun Jung Kim, Da Bin Choi
  • USE FOR PREVENTING AND TREATING MYELOID-DERIVED SUPPRESSOR CELL-RELATED DISEASES
    Publication number: 20220119518
    Abstract: The present invention relates to an antibody or an antigen-binding fragment thereof specifically binding to CD66c which is expressed in myeloid-derived suppressor cell (MDSC) and a use thereof, and specifically to an antibody or an antigen-binding fragment thereof specifically binding to CD66c, a pharmaceutical composition or a diagnosing composition including the same. The anti-CD66c antibody of the present invention can be used usefully for the treatment of various diseases by targeting MDSC which can induce the immunosuppression.
    Type: Application
    Filed: May 14, 2019
    Publication date: April 21, 2022
    Inventors: Soseul KIM, Jeong Won HONG, Gil Yong JI, Sangsoon YOON, Hyung-Geun SONG
  • ANTIBODY BINDING TO CARBONIC ANHYDRASE AND USE THEREOF
    Publication number: 20220033523
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Application
    Filed: September 30, 2021
    Publication date: February 3, 2022
    Inventors: Yoo Ri MOON, Sangsoon Yoon, Jeong Won Hong, Eun Jung Kim, Da Bin Choi
  • Antibody binding to carbonic anhydrase and use thereof
    Patent number: 11192959
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: December 7, 2021
    Assignee: APROGEN MEDICINES INC.
    Inventors: Yoo Ri Moon, Sangsoon Yoon, Jeong Won Hong, Eun Jung Kim, Da Bin Choi
  • ANTIBODY BINDING TO CARBONIC ANHYDRASE AND USE THEREOF
    Publication number: 20190276557
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Application
    Filed: November 14, 2017
    Publication date: September 12, 2019
    Inventors: Yoo Ri MOON, Sangsoon YOON, Jeong Won HONG, Eun Jung KIM, Da Bin CHOI